During the past decade, Wilmot Cancer Institute Radiation Oncology at Greece conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 3 clinical trials were completed, i.e. on average, 42.9% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 2 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Wilmot Cancer Institute Radiation Oncology at Greece" #1 sponsor was "National Cancer Institute (NCI)" with 6 trials, followed by "ECOG-ACRIN Cancer Research Group" with 2 trials sponsored, "Radiation Therapy Oncology Group" with 2 trials sponsored, "Alliance for Clinical Trials in Oncology" with 1 trials sponsored and "Gynecologic Oncology Group" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Wilmot Cancer Institute Radiation Oncology at Greece" #1 collaborator was "National Cancer Institute (NCI)" with 7 trials as a collaborator, "NRG Oncology" with 6 trials as a collaborator and "Canadian Cancer Trials Group" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Wilmot Cancer Institute Radiation Oncology at Greece" are "Stage IB Lung Non-Small Cell Carcinoma AJCC v7" (2 trials), "Stage II Lung Non-Small Cell Cancer AJCC v7" (2 trials), "Stage IIA Lung Non-Small Cell Carcinoma AJCC v7" (2 trials), "Stage IIB Lung Non-Small Cell Carcinoma AJCC v7" (2 trials) and "Stage IIIA Lung Non-Small Cell Cancer AJCC v7" (2 trials). Many other conditions were trialed in "Wilmot Cancer Institute Radiation Oncology at Greece" in a lesser frequency.

Most popular intervention types in "Wilmot Cancer Institute Radiation Oncology at Greece" are "Drug" (10 trials), "Other" (10 trials), "Radiation" (10 trials), "Procedure" (4 trials) and "Biological" (3 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (6 trials), "Quality-of-Life Assessment" (6 trials), "Radiation Therapy" (4 trials), "Biospecimen Collection" (3 trials) and "Carboplatin" (3 trials). Other intervention names were less common.

The vast majority of trials in "Wilmot Cancer Institute Radiation Oncology at Greece" are 9 trials for "All" genders, 2 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Wilmot Cancer Institute Radiation Oncology at Greece". undefined are not yet recruiting, 5 are recruiting, 8 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Wilmot Cancer Institute Radiation Oncology at Greece, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Wilmot Cancer Institute Radiation Oncology at Greece, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".